H. Chabre

发表

Standardization of allergen products: 1. Detailed characterization of GMP‐produced recombinant Bet v 1.0101 as biological reference preparation

R. Van Ree, S. Vieths, K. Buchheit, 2009, Allergy.

Expression and Characterization of Natural-Like Recombinant Der p 2 for Sublingual Immunotherapy

P. Moingeon, L. Mascarell, S. Tourdot, 2012, International Archives of Allergy and Immunology.

Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction

A. Louise, P. Moingeon, L. Mascarell, 2009, Allergy.

Glycoproteins are species-specific markers and major IgE reactants in grass pollens.

P. Moingeon, V. Gomord, L. Faye, 2012, Plant biotechnology journal.

Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria.

J. Bach, Z. Amoura, C. Lotton, 1994, Arthritis and rheumatism.

Sialylated Fetuin‐A as a candidate predictive biomarker for successful grass pollen allergen immunotherapy

P. Devillier, P. Moingeon, S. Chollet-Martin, 2017, The Journal of allergy and clinical immunology.

Binding of nucleosomes to a cell surface receptor: Redistribution and endocytosis in the presence of lupus antibodies

Z. Amoura, J. Bach, C. Lotton, 1996, European journal of immunology.

Patterns of IgE sensitization in house dust mite‐allergic patients: implications for allergen immunotherapy

F. Chew, P. Moingeon, T. Batard, 2016, Allergy.

Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy

R. Zeldin, F. Horak, P. Moingeon, 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

New Insights into Ragweed Pollen Allergens

P. Moingeon, L. Mascarell, E. Nony, 2015, Current Allergy and Asthma Reports.

Toll‐like receptor 2 agonist Pam3CSK4 enhances the induction of antigen‐specific tolerance via the sublingual route

A. Louise, P. Moingeon, L. Mascarell, 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Identification of the cysteine protease Amb a 11 as a novel major allergen from short ragweed.

P. Moingeon, L. Mascarell, J. Bouley, 2015, The Journal of allergy and clinical immunology.

A synthetic triacylated pseudo-dipeptide molecule promotes Th1/TReg immune responses and enhances tolerance induction via the sublingual route.

P. Moingeon, L. Mascarell, H. Chabre, 2007, Vaccine.

Urtica dioica agglutinin, a Vβ8.3‐specific superantigen, prevents the development of the systemic lupus erythematosus‐like pathology of MRL lpr/lpr mice

P. Kourilsky, P. Truffa-bachi, P. Musette, 1996 .

Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells.

A. Louise, P. Moingeon, L. Mascarell, 2008, The Journal of allergy and clinical immunology.

Marked depletion at the late pro‐B cell stage in the bone marrow of lpr mice correlates with the development of lymphadenopathy but not autoimmunity

Corinne Garcia, H. Chabre, N. Dautigny, 1996, European journal of immunology.

Production and Proteomic Characterization of Pharmaceutical-Grade Dermatophagoides pteronyssinus and Dermatophagoides farinae Extracts for Allergy Vaccines

F. Chew, P. Moingeon, X. Bi, 2006, International Archives of Allergy and Immunology.

Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity.

J. Piette, Z. Amoura, P. Cacoub, 1997, Arthritis and rheumatism.

Characterization of Wild-Type Recombinant Bet v 1a as a Candidate Vaccine against Birch Pollen Allergy

R. Valenta, P. Valent, A. Chenal, 2005, International Archives of Allergy and Immunology.

Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc Group.

Z. Amoura, L. Musset, P. Cacoub, 1997, The Journal of rheumatology.

Molecular variability of group 1 and 5 grass pollen allergens between Pooideae species: implications for immunotherapy

E. Ezan, B. Maillère, P. Moingeon, 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Recombinant Fusion Proteins Assembling Der p 1 and Der p 2 Allergens from Dermatophagoides pteronyssinus

P. Moingeon, T. Batard, E. Nony, 2010, International Archives of Allergy and Immunology.

Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.

J. Bach, J. Piette, Z. Amoura, 2000, Arthritis and rheumatism.

High throughput screening of mixed-mode sorbents and optimisation using pre-packed lab-scale columns for the purification of the recombinant allergen rBet v 1a.

Philippe Moingeon, P. Moingeon, Vincent Ravault, 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Early anti‐nucleosome autoantibodies from a single MRL +/+ mouse: fine specificity, V gene structure and pathogenicity

Z. Amoura, G. Mostoslavsky, J. Bach, 1998, European journal of immunology.

Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus.

J. Piette, Z. Amoura, P. Godeau, 1995, Arthritis and rheumatism.

Anti-histone reactivity in systemic lupus erythematosus sera: a disease activity index linked to the presence of DNA:anti-DNA immune complexes.

D. Choquette, J. Viard, H. Chabre, 1992, Autoimmunity.

Mass spectrometric investigation of molecular variability of grass pollen group 1 allergens.

E. Ezan, P. Moingeon, F. Fenaille, 2009, Journal of proteome research.

Production of native and modified recombinant Der p 1 molecules in tobacco plants

P. Moingeon, V. Gomord, H. Laparra, 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Impact of the standardization unit’s definition on the in vitro biological potency of allergen extracts

L. Mascarell, T. Batard, H. Chabre, 2023, Exploration of Asthma & Allergy.